Discovery of Novel Cyclic Ethers with Synergistic Antiplasmodial Activity in Combination with Valinomycin
With drug resistance threatening our first line antimalarial treatments, novel chemotherapeutics need to be developed. Ionophores have garnered interest as novel antimalarials due to their theorized ability to target unique systems found in the <i>Plasmodium</i>-infected erythrocyte. In...
Main Authors: | Daniel J. Watson, Paul R. Meyers, Kojo Sekyi Acquah, Godwin A. Dziwornu, Christopher Bevan Barnett, Lubbe Wiesner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/24/7494 |
Similar Items
-
Mechanically interlocked molecular architectures of valinomycin as cancer targeted prodrugs
by: Yoshihiro Tachihara, et al.
Published: (2022-08-01) -
The Nonribosomal Peptide Valinomycin: From Discovery to Bioactivity and Biosynthesis
by: Shuhui Huang, et al.
Published: (2021-04-01) -
Polymorphic Forms of Valinomycin Investigated by NMR Crystallography
by: Jiří Czernek, et al.
Published: (2020-07-01) -
Valinomycin as a potential antiviral agent against coronaviruses: A review
by: Dong Zhang, et al.
Published: (2020-10-01) -
Ionophore Antibiotics Inhibit Type II Feline Coronavirus Proliferation In Vitro
by: Yoshikazu Tanaka, et al.
Published: (2022-08-01)